The effect of dopamine on the rapidly adapting receptors in the dog lung

Pulm Pharmacol Ther. 2000;13(1):39-42. doi: 10.1006/pupt.2000.0229.

Abstract

The effect of an infusion of dopamine (50 microg/kg per min) on both resting and histamine-stimulated discharge of rapidly adapting receptors has been studied in the dog lung. In dogs pretreated with propranolol and phentolamine (1 mg/kg) dopamine inhibited the ability of histamine to stimulate the rapidly adapting receptors. This inhibition was attenuated by sulpiride, a selective D(2)antagonist, (0.5 mg/kg i.v.). Dopamine did not affect the increases in R(L)or the falls in C(dyn)produced by histamine. It is suggested that dopamine may play a role in the control of lung function by reducing the ability of sensory nerves to produce harmful reflex activity.

MeSH terms

  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / pharmacology*
  • Airway Resistance / drug effects
  • Animals
  • Asthma / prevention & control*
  • Chemoreceptor Cells / drug effects*
  • Disease Models, Animal
  • Dogs
  • Dopamine / administration & dosage
  • Dopamine / pharmacology*
  • Dopamine Antagonists / pharmacology
  • Female
  • Histamine / pharmacology
  • Injections, Intravenous
  • Lung / drug effects*
  • Lung / innervation
  • Lung / physiology
  • Lung Compliance / drug effects
  • Male
  • Sulpiride / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Dopamine Antagonists
  • Sulpiride
  • Histamine
  • Dopamine